Selected article for: "evolution describe and new disease"
Author: González-Hermosillo, J Antonio; Martínez-López, Jhanea Patricia; Carrillo-Lampón, Sofía Antonieta; Ruiz-Ojeda, Dayanara; Herrera-Ramírez, Sharon; Amezcua-Guerra, Luis M.; Martínez-Alvarado, María del Rocío
Title: Post-Acute COVID-19 Symptoms, a Potential Link with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A 6-Month Survey in a Mexican Cohort
  • Cord-id: xtfu0ra6
  • Document date: 2021_6_8
    • ID: xtfu0ra6
    Snippet: The aim of this study was to describe the clinical evolution during 6 months of follow-up of adults recovered from COVID-19. We tried to determine how many met the definition of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A total of 130 patients (51.0 ± 14 years, 34.6% female) were enrolled. Symptoms were common, participants reported a median number of 9 (IQR 5–14) symptoms. Fatigue was the most common symptom (61/130; 46.9%). Patients with fatigue were older 53.9 ± 13.5 ye
    Document: The aim of this study was to describe the clinical evolution during 6 months of follow-up of adults recovered from COVID-19. We tried to determine how many met the definition of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS). A total of 130 patients (51.0 ± 14 years, 34.6% female) were enrolled. Symptoms were common, participants reported a median number of 9 (IQR 5–14) symptoms. Fatigue was the most common symptom (61/130; 46.9%). Patients with fatigue were older 53.9 ± 13.5 years compared with 48.5 ± 13.3 years in those without fatigue (p = 0.02) and had a longer length of hospital stay, 17 ± 14 days vs. 13 ± 10 days (p = 0.04). There was no difference in other comorbidities between patients with fatigue and those without it, and no association between COVID-19 severity and fatigue. After multivariate adjustment of all baseline clinical features, only age 40 to 50 years old was positively associated with fatigue, OR 2.5 (95% CI 1.05–6.05) p = 0.03. In our survey, only 17 (13%) patients met the Institute of Medicine’s criteria for “systemic exertion intolerance disease,” the new name of ME/CFS. In conclusion, in some patients, the features of post-acute COVID-19 syndrome overlap with the clinical features of ME/CFS.

    Search related documents:
    Co phrase search for related documents
    • absence presence and acute illness: 1, 2, 3, 4, 5, 6
    • absence presence and acute period: 1
    • absence presence and acute phase: 1, 2, 3, 4, 5, 6, 7, 8
    • absence presence and acute respiratory syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and acute symptom: 1
    • absence presence and acute syndrome: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • absence presence and logistic regression model: 1, 2, 3, 4, 5, 6, 7
    • absence presence and long acute: 1
    • absolute frequency and acute respiratory syndrome: 1, 2
    • absolute frequency and acute syndrome: 1, 2
    • absolute frequency and logistic regression model: 1
    • acute challenge and long acute: 1, 2, 3, 4
    • acute illness and admission laboratory finding: 1
    • acute illness and logistic regression model: 1, 2, 3, 4, 5
    • acute illness and long acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute period and logistic regression model: 1, 2
    • acute period and long acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute phase and logistic regression model: 1, 2, 3, 4, 5
    • acute phase and long acute: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25